Kuzelova 2008 Gen Physiol Biophys: Difference between revisions

From Bioblast
No edit summary
No edit summary
Β 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Kuzelova M, Adameova A, Sumbalova Z, Paulikova I, HarcarovΓ‘ A, Svec P, Kucharska J. (2008) The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats. Gen Physiol Biophys. 27(4):291-8.
|title=Kuzelova M, Adameova A, Sumbalova Z, Paulikova I, HarcarovΓ‘ A, Svec P, Kucharska J. (2008) The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats. Gen Physiol Biophys. 27:291-8.
|info=http://www.ncbi.nlm.nih.gov/pubmed/19202203
|info=[http://www.ncbi.nlm.nih.gov/pubmed/19202203 PMID: 19202203 ]
|authors=Kuzelova M, Adameova A, Sumbalova Z, Paulikova I, Harcarova A, Svec P, Kucharska
|authors=Kuzelova M, Adameova A, Sumbalova Z, Paulikova I, Harcarova A, Svec P, Kucharska
|year=2008
|year=2008
Line 8: Line 8:
antioxidant/oxidant balance in a rat model of diabetes mellitus and
antioxidant/oxidant balance in a rat model of diabetes mellitus and
hypercholesterolaemia was studied. In the diabetic-hypercholesterolaemic rats the
hypercholesterolaemia was studied. In the diabetic-hypercholesterolaemic rats the
signs of oxidative stress-decreased alpha-tocopherol/cholesterol in the plasma (p
signs of oxidative stress-decreased alpha-tocopherol/cholesterol in the plasma (''p''
< 0.01) and alpha-tocopherol in liver (p < 0.001) together with increased lipid
< 0.01) and alpha-tocopherol in liver (''p'' < 0.001) together with increased lipid
peroxidation in the liver (TBARS, p < 0.05) were found. Increased coenzyme Q9
peroxidation in the liver (TBARS, ''p'' < 0.05) were found. Increased coenzyme Q9
concentrations in the plasma (p < 0.05) and liver (p < 0.01), coenzyme Q10 in the
concentrations in the plasma (''p'' < 0.05) and liver (''p'' < 0.01), coenzyme Q10 in the
myocardium (p < 0.05) and in the liver (p < 0.01) may indicate adaptation to
myocardium (''p'' < 0.05) and in the liver (''p'' < 0.01) may indicate adaptation to
oxidative stress. Administration of simvastatin (10 mg/kg) to the
oxidative stress. Administration of simvastatin (10 mg/kg) to the
diabetic-hypercholesterolaemic rats counteracted increased myocardial (coenzyme
diabetic-hypercholesterolaemic rats counteracted increased myocardial (coenzyme
Q10, p < 0.05) and liver (total coenzyme Q9, p < 0.05) coenzyme Q concentrations Β 
Q10, ''p'' < 0.05) and liver (total coenzyme Q9, ''p'' < 0.05) coenzyme Q concentrations Β 
but did not improve alpha-tocopherol depletion and increased formation of TBARS
but did not improve alpha-tocopherol depletion and increased formation of TBARS
in the liver. Even though simvastatin treatment did not induce coenzyme Q
in the liver. Even though simvastatin treatment did not induce coenzyme Q
Line 24: Line 24:
effect of statins on the coenzyme Q levels in the animal models of pathological
effect of statins on the coenzyme Q levels in the animal models of pathological
conditions known to change the initial antioxidant defence system.
conditions known to change the initial antioxidant defence system.
|keywords=hypercholesterolaemia, diabetes, coenzyme Q, a-tocopherol, simvastatin, rat, liver
|keywords=Hypercholesterolaemia, Diabetes, Coenzyme Q, a-tocopherol, Simvastatin, Rat, Liver
|mipnetlab=SK Bratislava Sumbalova Z
}}
}}
{{Labeling
{{Labeling
|injuries=RONS; Oxidative Stress, Mitochondrial Disease; Degenerative Disease and Defect
|diseases=Diabetes
|injuries=Oxidative stress;RONS, Mitochondrial disease
|organism=Rat
|organism=Rat
|tissues=Heart, Liver
|tissues=Heart, Liver
|additional=daibetes
|additional=daibetes
}}
}}

Latest revision as of 15:42, 27 March 2018

Publications in the MiPMap
Kuzelova M, Adameova A, Sumbalova Z, Paulikova I, HarcarovΓ‘ A, Svec P, Kucharska J. (2008) The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats. Gen Physiol Biophys. 27:291-8.

Β» PMID: 19202203

Kuzelova M, Adameova A, Sumbalova Z, Paulikova I, Harcarova A, Svec P, Kucharska (2008) Gen Physiol Biophys

Abstract: The effect of simvastatin administered for 10 days on coenzyme Q and antioxidant/oxidant balance in a rat model of diabetes mellitus and hypercholesterolaemia was studied. In the diabetic-hypercholesterolaemic rats the signs of oxidative stress-decreased alpha-tocopherol/cholesterol in the plasma (p < 0.01) and alpha-tocopherol in liver (p < 0.001) together with increased lipid peroxidation in the liver (TBARS, p < 0.05) were found. Increased coenzyme Q9 concentrations in the plasma (p < 0.05) and liver (p < 0.01), coenzyme Q10 in the myocardium (p < 0.05) and in the liver (p < 0.01) may indicate adaptation to oxidative stress. Administration of simvastatin (10 mg/kg) to the diabetic-hypercholesterolaemic rats counteracted increased myocardial (coenzyme Q10, p < 0.05) and liver (total coenzyme Q9, p < 0.05) coenzyme Q concentrations but did not improve alpha-tocopherol depletion and increased formation of TBARS in the liver. Even though simvastatin treatment did not induce coenzyme Q deficiency in plasma, heart and liver of the diabetic-hypercholesterolaemic rats as compared to the control levels, it was not able to prevent completely the changes in antioxidant/oxidant balance induced by diabetes and hypercholesterolaemia. The results highlight the importance of studying the effect of statins on the coenzyme Q levels in the animal models of pathological conditions known to change the initial antioxidant defence system. β€’ Keywords: Hypercholesterolaemia, Diabetes, Coenzyme Q, a-tocopherol, Simvastatin, Rat, Liver

β€’ O2k-Network Lab: SK Bratislava Sumbalova Z


Labels: Pathology: Diabetes  Stress:Oxidative stress;RONS, Mitochondrial disease  Organism: Rat  Tissue;cell: Heart, Liver 




daibetes 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.